Skip to main content
Clinical Trials/IRCT20230204057318N2
IRCT20230204057318N2
Recruiting
Phase 3

Investigating the effect of simultaneous infusion of lidocaine and ketamine compared to single infusion of lidocaine and ketamine on neuromonitoring in spine surgeries

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Candidate patients for spine surgery under neuromonitoring
  • Age 18 to 65 years
  • Patients with ASA class 1 or 2

Exclusion Criteria

  • Absence of any significant laboratory disturbance in coagulation, kidney, liver function tests, blood cell count
  • No history of drug addiction
  • Insensitivity to ketamine or local anesthetics
  • Absence of contraindications for performing MEP (epilepsy, cerebral cortex damage, increased intracranial pressure, cardiac pacemaker, intracranial electrodes, or vascular clamps)

Outcomes

Primary Outcomes

Not specified

Similar Trials